Table 2. SwissADME values of selected indole based diaza-sulphonamide compounds (1-9).
Compound | log Kp (cm/s) | GI absorption | BBB permeant | Pgp substrate | CYP1A2 inhibitor | CYP2C19 inhibitor | CYP2C9 inhibitor | CYP2D6 inhibitor | CYP3A4 inhibitor |
1 | -6.54 | High | No | No | Yes | Yes | Yes | Yes | Yes |
2 | -6.36 | High | No | No | Yes | Yes | Yes | Yes | Yes |
3 | -6.36 | High | No | No | Yes | Yes | Yes | Yes | Yes |
4 | -6.19 | Low | No | No | Yes | Yes | Yes | Yes | Yes |
5 | -6.3 | Low | No | No | Yes | Yes | Yes | Yes | Yes |
6 | -6.12 | Low | No | No | Yes | Yes | Yes | Yes | Yes |
7 | -6.3 | Low | No | No | Yes | Yes | Yes | Yes | Yes |
8 | -6.06 | Low | No | No | Yes | Yes | Yes | Yes | Yes |
9 | -6.12 | Low | No | No | Yes | Yes | Yes | Yes | Yes |
Doxorubicin | -8.71 | Low | No | Yes | No | No | No | No | No |
Paclitaxel | -8.91 | Low | No | Yes | No | No | No | No | No |
Tamoxifen | -3.5 | Low | No | Yes | No | Yes | No | Yes | No |